Información del autor
Documentos disponibles escritos por este autor (10)
Añadir el resultado a su cesta Hacer una sugerencia Refinar búsqueda
texto impreso
Elera-Fitzcarrald, C. ; Reátegui-Sokolova, C. ; Gamboa-Cárdenas, R.V. ; Medina, M. ; Zevallos, F. ; Pimentel-Quiroz, V.R. ; Zeña-Huancas, P.A. ; Pastor-Asurza, C.A. ; Perich-Campos, R.A. ; Rodríguez-Bellido, Z.J. ; Alarcón, G.S. ; Ugarte-Gil, M.F. | SAGE PUBLICATIONS LTD | 2020-12-14T16:06:20ZObjective: To define the factors associated with fatigue in Mestizo patients with Systemic Lupus Erythematosus (SLE). Methods: This is a cross-sectional study of SLE patients from a single center cohort. Visits were performed every six months. F[...]texto impreso
Ugarte-Gil, M.F. ; Gamboa-Cárdenas, R.V. ; Reátegui-Sokolova, C. ; Medina-Chinchón, M. ; Zevallos, F. ; Elera-Fitzcarrald, C. ; Pimentel-Quiroz, V. ; Cucho-Venegas, J.M. ; Rodriguez-Bellido, Z. ; Pastor-Asurza, C.A. ; Alarcón, G.S. ; Perich-Campos, R. | John Wiley and Sons Inc. | 2020-12-14T16:10:20ZObjective: To determine if low disease activity state (LDAS)/remission predicts a better health-related quality of life (HRQoL). Methods: Patients with systemic lupus erythematosus from a single center and having completed at least 2 visits were[...]texto impreso
Quintana, R. ; Pons-Estel, G.J. ; Roberts, K. ; Sacnún, M. ; Serrano, R. ; Nieto, R. ; Conti, S. ; Gervasoni, V. ; Catoggio, L.J. ; Soriano, E.R. ; Scolnik, M. ; Garcia, M.A. ; Alvarellos, A. ; Saurit, V. ; Berbotto, G.A. ; Sato, E.I. ; Costallat, L.T.L. ; Neto, E.F.B. ; Bonfa, E. ; Xavier, R.M. ; de Oliveira e Silva Montandon, A.C. ; Molina-Restrepo, J.F. ; Iglesias-Gamarra, A. ; Guibert-Toledano, M. ; Reyes-Llerena, G.A. ; Massardo, L. ; Neira, O.J. ; Cardiel, M.H. ; Barile-Fabris, L.A. ; Amigo, M.-C. ; Silveira, L.H. ; Torre, I.G.D.L. ; Acevedo-Vásquez, E.M. ; Ugarte-Gil, M.F. ; Alfaro-Lozano, J.L. ; Segami, M.I. ; Chacon-Diaz, R. ; Esteva-Spinetti, M.H. ; Gomez-Puerta, J.A. ; Alarcón, G.S. ; Pons-Estel, B.A. | SAGE PUBLICATIONS LTD | 2020-12-14T16:10:05ZObjectives: This study aimed to compare the clinical features, damage accrual, and survival of patients with familial and sporadic systemic lupus erythematosus (SLE). Methods: A multi-ethnic, multinational Latin American SLE cohort was studied. [...]texto impreso
Elera-Fitzcarrald, C. ; Vega, K. ; Gamboa-Cárdenas, R.V. ; Zúñiga, K. ; Medina, M. ; Pimentel-Quiroz, V. ; Pastor-Asurza, C. ; Perich-Campos, R. ; Rodríguez Bellido, Z. ; Griffin, R. ; Aranow, C. ; Alarcón, G.S. ; Calvo, A. ; Ugarte-Gil, M.F. | NLM (Medline) | 2020-12-14T16:06:21ZOBJECTIVE: The aim of this study was to compare patient and physician (MD) assessment of disease activity in systemic lupus erythematosus patients. METHODS: This cross-sectional study was conducted between August 2016 and December 2017 at 2 Peru[...]texto impreso
Ugarte-Gil, M.F. ; Gamboa-Cárdenas, R.V. ; Reátegui-Sokolova, C. ; Pimentel-Quiroz, V.R. ; Zeña-Huancas, P. ; Elera-Fitzcarrald, C. ; Garcia-Hirsh, S. ; Gil, L. ; Pastor-Asurza, C.A. ; Rodriguez-Bellido, Z. ; Merrill, J. ; Askanase, A.D. ; Alarcon, G. ; Perich-Campos, R.A. | BMJ Publishing Group | 2020-12-14T16:10:21ZObjective The Lupus Foundation of America Rapid Evaluation of Activity in Lupus (LFA-REAL) clinician-reported outcome (ClinRO) and the LFA-REAL patient-reported outcome (PRO) were developed in order to capture manifestations of SLE from the pers[...]texto impreso
Elera-Fitzcarrald, C. ; Vega, K. ; Gamboa-Cárdenas, R.V. ; Zúñiga, K. ; Zevallos, F. ; Reátegui-Sokolova, C. ; Pastor-Asurza, C. ; Perich-Campos, R. ; Rodríguez Bellido, Z. ; Aranow, C. ; Alarcón, G.S. ; Calvo, A. ; Ugarte-Gil, M.F. | NLM (Medline) | 2020-12-14T16:06:21ZOBJECTIVE: To determine the reliability of SLE patients' disease activity measurements. METHODS: This was a cross-sectional study conducted (August 2016-December 2017) at 2 main public Peruvian hospitals, 1 with a comprehensive lupus care progra[...]texto impreso
Alarcón, G.S. ; Ugarte-Gil, M.F. ; Pons-Estel, G. ; Vilá, L.M. ; Reveille, J.D. ; McGwin, G., Jr. | Sage publications | 2019-12-06T20:57:49ZObjective: The objective of this report is to determine the impact of remission and low disease activity state (LDAS) on damage accrual and mortality in systemic lupus erythematosus (SLE) patients. Patients and methods: Visits from the Lupus in [...]texto impreso
Alarcón, G.S. ; Ugarte-Gil, M.F. ; Pons-Estel, G. ; Vilá, L.M. ; Reveille, J.D. ; McGwin, G., Jr. | Sage publications | 2019-07-04T17:00:21ZObjective: The objective of this report is to determine the impact of remission and low disease activity state (LDAS) on damage accrual and mortality in systemic lupus erythematosus (SLE) patients. Patients and methods: Visits from the Lupus in [...]texto impreso
Elera-Fitzcarrald, C. ; Reátegui-Sokolova, C. ; Gamboa-Cárdenas, R.V. ; Medina, M. ; Zevallos, F. ; Pimentel-Quiroz, V.R. ; Cucho-Venegas, J.M. ; Alfaro-Lozano, J. ; Rodriguez-Bellido, Z. ; Pastor-Asurza, C.A. ; Perich-Campos, R.A. ; Alarcón, G.S. ; Ugarte-Gil, M.F. | BMJ Publishing Group | 2020-07-14T00:01:09ZIntroduction: Serum uric acid levels have been reported as predictors of cardiovascular, pulmonary, neurological and renal morbidity in patients with SLE. However, their role in cumulative global damage in these patients has not yet been determi[...]texto impreso
Despite significant advances in our understanding of the pathogenesis of systemic lupus erythematosus (SLE), there are only a few drugs approved by the regulatory agencies across the world for the treatment of these patients; in fact, many of th[...]
